Milad Nazarzadeh

Milad Nazarzadeh is a Senior Research Fellow in Cardiovascular and Genetic Epidemiology at the University of Oxford. His research integrates multidisciplinary methodologies, including individual participant data (IPD) meta-analysis, genetic data analysis, electronic health records, and artificial intelligence, to generate robust evidence on cardiovascular risk factors, treatments, and preventive strategies. His key areas of expertise include blood pressure, diabetes, valvular heart diseases, cardiovascular risk management, pharmacogenomics, and pharmacoepidemiology.

Milad earned his DPhil from the University of Oxford, where he was awarded an Immediate Postdoctoral Research Fellowship by the British Heart Foundation. His current research focuses on valvular heart diseases, an underexplored area of cardiovascular medicine, with the goal of advancing our understanding and identifying innovative treatment strategies. He is particularly interested in designing and conducting randomised controlled trials (RCTs) to test novel treatments and explore drug repurposing opportunities in cardiovascular medicine. Additionally, Milad is passionate about leveraging OMICs data to drive drug discovery and repurposing efforts, aiming to uncover new therapeutic approaches for cardiovascular diseases.

Beyond his work in cardiovascular research, Milad has a keen interest in exploring the therapeutic potential of psychedelics, particularly in relation to mental health and chronic disease management. He is enthusiastic about investigating the emerging intersections of psychedelic research with cardiovascular health and broader healthcare innovation.